I run a sublingual strip company. I've spent the last two years reading pharmacokinetic studies, talking to formulators, and building products around the idea that the under-the-tongue route is better for certain ingredients. And I'm going to tell you something most brands in my category won't: a lot of what the sublingual supplement industry claims about absorption is either unsupported, exaggerated, or flatly contradicted by the research it cites.
This isn't a takedown piece. Sublingual absorption is real pharmacology — it saves lives in emergency rooms and delivers breakthrough pain medication to cancer patients. But the distance between what sublingual delivery actually does in peer-reviewed trials and what supplement brands say it does on their product pages is wide enough to drive a truck through. Here's what I can defend.
The caffeine experiment that explains everything
Start with the simplest possible test. Caffeine is a tiny molecule (194 Daltons), it's lipophilic, and it's one of the most-studied compounds in pharmacology. If any supplement ingredient should show a sublingual speed advantage, it's caffeine.
In 2025, researchers at the University of Guelph ran a clean crossover trial: 14 adults, 60 mg caffeine delivered via sublingual mouth spray versus coffee versus energy drink. The result was unambiguous. The sublingual spray did not raise blood caffeine any faster than simply drinking coffee (McCarthy et al., European Journal of Applied Physiology, 2025).
Same year, different format: caffeine delivered via chewing gum — which sits against the oral mucosa for 5 to 20 minutes — showed a peak blood level roughly 40 minutes faster than a capsule (Tmax 44–80 min for gum vs 84–120 min for capsule) and approximately 30 times more plasma caffeine at the 5-minute mark. Two distinct plasma peaks confirmed the drug was absorbing through both the oral mucosa and the GI tract (Food & Function, 2019; International Journal of Pharmaceutics).
Same molecule. Same mouth. Opposite results. The difference wasn't the route — it was how long the caffeine stayed in contact with the tissue. A spray that's swallowed in seconds is just a weird way to drink your coffee. A gum that parks against your cheek for 15 minutes is genuine mucosal delivery.
That distinction — contact time, not route — is the variable the entire sublingual supplement industry prefers not to discuss.
Sublingual absorption is real pharmacology
Before I criticize how the mechanism is marketed, I need to be honest about what it actually does.
The tissue under your tongue is non-keratinized, thin, and richly vascularized. Compounds that cross it enter the superior vena cava directly, bypassing both the GI tract and the liver's first-pass metabolism. For drugs that are destroyed by stomach acid or heavily metabolized by the liver, this is transformative.
Nitroglycerin goes under the tongue during angina because oral bioavailability is essentially zero — the liver metabolizes it before it ever reaches the heart. Buprenorphine, used in opioid dependence treatment, jumps from 10–15% oral bioavailability to approximately 50–70% sublingually. Fentanyl for breakthrough cancer pain is delivered as sublingual tablets and sprays because oral first-pass metabolism would destroy it.
These are not marketing stories. These are established pharmacological interventions that depend on a real biological mechanism. But notice the pattern: every successful sublingual drug is a potent, low-dose, lipophilic small molecule with a severe first-pass problem. Vitamins and most supplement ingredients are, with very few exceptions, none of those things.
Contact time: the variable marketing hides
Here's the part that makes the supplement industry uncomfortable. For a compound to absorb through the sublingual mucosa, it needs to stay in contact with the tissue. Not dissolve fast. Stay.
Your mouth is not a passive container. Saliva flows continuously, washing dissolved material toward the throat. Food, mouth movement, and involuntary swallowing all clear the sublingual space. Pharmaceutical researchers describe this plainly: sublingual delivery systems face "a continuous flow of saliva that leads to a loss of drug by swallowing," and this can result in "reduced or no pharmaceutical efficacy" (Pharmaceutics, 2022). That's why prescription sublingual products use mucoadhesive formulations designed to stick to the tissue for extended periods.
A spray that hits the underside of your tongue and is swallowed two seconds later has had essentially no meaningful mucosal contact time. A fast-dissolving strip that breaks apart in 30 seconds has had very little. PBPK modeling of risperidone orodispersible film — undertaken specifically because rapid oral dissolution does not by itself establish transmucosal absorption — confirmed what the physiology predicts: a product can dissolve in 3 seconds and be 100% swallowed (European Journal of Pharmaceutics and Biopharmaceutics, 2020).
This is the gap between "dissolves in your mouth" and "absorbed through your mouth." They are not the same event. And the practical instruction that follows is simple: if something is genuinely meant to be sublingual, the brand should tell you to hold it under your tongue and avoid swallowing for as long as tolerable. Dosing instructions that don't mention hold time are a red flag about whether the formulator intended mucosal delivery at all.
The five gates every sublingual ingredient must pass
Based on the pharmacological literature, a sublingual absorption claim is plausible only if all five of these hold:
Gate 1: Molecular weight. The estimated sublingual mucosa cutoff is roughly 1,675 Daltons — much more permeable than skin (which caps around 500 Da), but still a hard limit. Collagen peptides at 3,000–5,000 Da, beta-glucan polysaccharides, and whole probiotic cells (micron-scale, not Dalton-scale) are not candidates.
Gate 2: Lipophilicity. The lipids in the oral mucous membrane are the main barrier to hydrophilic (water-soluble) drugs. Non-polar molecules cross through lipid regions of the epithelium; polar molecules are restricted to narrow ionic channels and aqueous pores — a far less efficient route. Most water-soluble vitamins face an uphill permeability challenge sublingually.
Gate 3: Dose size. The sublingual space is small. A 1 mg melatonin delivery is physically plausible. 500 mg of magnesium, 1,000 mg of vitamin C, or 10 grams of collagen are not — regardless of any molecular property. Mass balance alone disqualifies most of the supplement aisle.
Gate 4: A first-pass problem worth solving. Without significant liver metabolism or GI degradation to escape, sublingual delivery has nothing to gain. This is precisely why vitamin B12 — which is dose-limited by intrinsic factor in the gut, not by first-pass metabolism — consistently shows no sublingual advantage in clinical trials.
Gate 5: Actual mucosal contact time. The formulation must keep the compound at the tissue long enough for meaningful absorption. A mucoadhesive system, an instructed multi-minute hold, or a slow-dissolving format. Not a spray or a strip that dissolves faster than you can read the instructions.
What actually works (the short list)
Melatonin is the honest win. Molecular weight 232 Da. Lipophilic. Low dose (0.3–3 mg). Oral bioavailability roughly 15% due to extensive first-pass metabolism (DeMuro et al., Journal of Clinical Pharmacology, 2000). A sublingual spray delivered Tmax of 23.3 ± 6.5 minutes versus approximately 41 minutes for an oral tablet, with significantly higher systemic exposure (PubMed 37438493). For a product whose entire purpose is falling asleep faster, that 18-minute difference is the outcome that matters. Not a magic absorption multiple — a measured, meaningful speed advantage.
Vitamin D3 works — sometimes. Molecular weight 384.6 Da. Lipophilic. Low dose. Mechanistically plausible. But systematic reviews of buccal D3 sprays versus capsules in healthy adults find no significant difference (Cambridge Proceedings of the Nutrition Society; British Journal of Nutrition). Where the advantage appears is in people with impaired gut absorption — IBD patients, bariatric surgery patients, certain malabsorption conditions. "Sublingual D3 helps when your gut is the bottleneck" is a defensible, specific, honest claim. "Sublingual D3 is better" is not.
Glutathione is preliminary but plausible. Molecular weight 307 Da. One crossover trial (n=20) found sublingual glutathione improved the GSH/GSSG oxidative stress ratio where oral glutathione did not (Schmitt et al., Redox Biology, 2015). But n=20, a single-population study with biomarker endpoints rather than direct plasma PK — encouraging, not conclusive. And glutathione is hydrophilic, which the permeability literature says should struggle across mucosa. I'd call this "worth watching" rather than "proven."
What doesn't work (and why brands sell it anyway)
Vitamin B12 is the industry's most awkward example. The NIH Office of Dietary Supplements states directly: "No evidence indicates that absorption rates of vitamin B12 in supplements vary by form of the vitamin." The canonical head-to-head trial — Sharabi et al., British Journal of Clinical Pharmacology, 2003 — randomized 30 subjects to sublingual versus oral B12 and found the two routes statistically indistinguishable. A 2025 systematic review and meta-analysis of 16 studies covering 6,098 participants confirmed: sublingual and oral B12 raise serum levels comparably (Frontiers in Pharmacology, 2025). This isn't a gap in the evidence. This is the evidence.
Why does sublingual B12 remain the most-marketed sublingual supplement? Because "absorbs better under the tongue" is a compelling story, the molecule is cheap to formulate, and few consumers read the primary literature. I'm including B12 in my own Energy strips — and I want to be clear that the format advantage there is convenience and adherence, not a bioavailability multiplier.
Probiotics and beta-glucans are category errors. Probiotics are defined as viable microorganisms that reach the intestine in an active state. The gut is the target organ. Beta-glucans cannot be hydrolyzed in saliva or stomach conditions; they reach the large intestine where gut bacteria metabolize them. A "sublingual probiotic" is not a delivery upgrade — it's a product trying to bypass the only place it can work.
Collagen peptides fail on physics. Typical collagen doses are 2.5–10 grams. Hydrolyzed collagen peptides range from 3,000 to 5,000 Da. They are hydrophilic. A sublingual film cannot carry grams of material, cannot deliver molecules that large across mucosa, and cannot make hydrophilic peptides lipophilic. Sublingual collagen is three simultaneous impossibilities marketed as innovation.
Curcumin is the subtlest failure. At 368 Da, it's comfortably under the sublingual molecular weight cutoff. But its ~1% oral bioavailability isn't caused by first-pass metabolism alone — it's driven by poor water solubility, extremely low intrinsic membrane permeability, rapid metabolism, and rapid systemic elimination (Anand et al., Molecular Pharmaceutics, 2007). Moving curcumin from your gut to your sublingual tissue doesn't fix any of those problems. It just relocates the same failure to a different surface. Small enough is not the same as absorbable.
The regulatory tell you can read from the label
Here's something the FTC has already weighed in on. The Commission alleged that marketers of Life Way vitamin sprays "did not have adequate evidence to support claims that vitamin sprays are more fully absorbed by the body than vitamins in pill form." A federal regulator has already ruled that the specific claim most sublingual supplement brands make requires substantiation they don't have.
The FTC's Health Products Compliance Guidance makes the standard clear: health-related claims require competent and reliable scientific evidence held before the claim runs — not after a challenge. An "absorbs 4× better" claim needs a human comparative bioavailability study on that ingredient, in that format, at that dose. Mechanistic plausibility, rat data, or a study on a different molecule does not count.
There's also a regulatory wrinkle most brands haven't considered. Under the FD&C Act, a "dietary supplement" is defined as something intended for ingestion. FDA and FTC have taken the position that sublingual products — intended to enter the body through mucosal tissue rather than through digestion — may not qualify as dietary supplements at all. The stronger a brand claims to bypass digestion entirely, the more it argues itself out of dietary-supplement status and into unapproved-new-drug territory. The harder the absorption claim, the weaker the regulatory footing.
The honest value proposition for strips
So if most sublingual supplement claims are oversold, why do I make strips?
Because the real data on non-pill formats tells a different story — one that's actually more compelling than "4× absorption" and has the advantage of being true.
Non-pill formats show approximately 34% higher adherence rates compared to traditional oral solids. 69% of consumers prioritize taste and flavor when purchasing supplements. 41% cite ease of use as a key purchase driver. These aren't pharmacokinetic claims requiring controlled trials — they're behavioral observations with straightforward measurement.
A strip dissolves in 30 seconds, needs no water, fits in a wallet, has no pill-swallowing barrier, and removes the friction that causes roughly 40% of supplement users to eventually abandon their routine. The supplement you actually take every day beats the one that's theoretically superior and sitting in a cupboard you haven't opened since March.
That's the argument I can make honestly. Founder's compulsion, not a marketing line. The routine I'd put my mom on — not because it absorbs 10× better, but because she'd actually do it.
Brands could make this truthful case and many don't, because "you'll remember to take it" doesn't land as hard as "absorbs 4× better" on a Facebook ad. That choice — the gap between what you can prove and what sells — is what this article is really about.
When to see a doctor instead of buying a supplement
No format — strip, pill, spray, gummy, or powder — is a substitute for clinical evaluation. See a healthcare provider if you're experiencing persistent fatigue that doesn't resolve with sleep, unexplained cognitive changes, symptoms that started after a medication change, or any condition you're trying to self-treat with supplements instead of medical care. A confirmed nutrient deficiency needs bloodwork and medical supervision, not a better delivery format.
Frequently asked questions
Do sublingual supplements actually work?
Sublingual delivery is proven pharmacology for specific drugs (nitroglycerin, buprenorphine, fentanyl). For supplements, the evidence is ingredient-specific: melatonin shows a genuine speed advantage, vitamin D3 may help in malabsorption conditions, and most other supplement ingredients show no sublingual benefit in clinical trials. A strip or spray delivers its labeled dose — whether the route adds pharmacokinetic value depends entirely on the specific compound.
Is sublingual better than swallowing a pill?
For the narrow category of low-dose, lipophilic, small molecules with significant first-pass metabolism — sometimes measurably yes. For most vitamins and supplement ingredients — the evidence says no. The practical advantage of non-pill formats is adherence and convenience, not absorption.
How long should I hold a sublingual supplement under my tongue?
As long as you can tolerate without swallowing — ideally 60 seconds or more. The caffeine research shows that seconds of contact time produces no mucosal absorption advantage, while minutes of contact time does. If a product's instructions don't mention hold time, question whether the formulator intended sublingual delivery at all.
Why do so many brands claim sublingual is better?
"Absorbs 4× better" converts better in advertising than "you'll actually remember to take it." The FTC has already challenged vitamin spray absorption claims for lacking adequate evidence. Most sublingual supplement marketing relies on the mechanism being real in pharmacology and consumers not checking whether it applies to their specific product.
What should I look for in a sublingual supplement?
Check whether the ingredient is low molecular weight (under ~1,000 Da), lipophilic, low-dose, and has a documented first-pass metabolism problem. Check whether the format provides meaningful mucosal contact time. And check whether the brand cites a human bioavailability study on their specific product — not a mechanistic argument, not a rat study, not data on a different compound.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Related reading
- Sublingual vs Oral Supplements: Where Your Ingredients Actually Go — Our foundational piece on what the sublingual route does and doesn't do for each XYNE ingredient.
- Bioavailability Explained: Why Format Determines What You Absorb — The science of how much of a labeled dose your body actually uses.
- First-Pass Metabolism, Explained Like You're a Smart Friend — The liver step that makes sublingual delivery relevant for some compounds and irrelevant for most.
- The Sublingual Mucosa: What 30 Seconds Under Your Tongue Actually Does — The tissue-level mechanics, and their limits.
- Your Body's 6 Filters: Why Most Supplement Formats Lose Before They Start — The six biological processes that reduce what you absorb from traditional formats.
- Sleep Onset: The 45 Minutes Your Melatonin Wastes — The one ingredient where sublingual speed genuinely matters for the outcome.
